Altered peptide ligands: Prospects for immune intervention in autoimmune disease

Altered peptide ligands: Prospects for immune intervention in autoimmune disease

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autor:	Fairchild, P
Format:	Journal article
Izdano:	1997

Slični predmeti

Altered peptide ligands: prospects for immune intervention in autoimmune disease.
od: Fairchild, P
Izdano: (1997)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
od: Chen, T, i dr.
Izdano: (2004)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.
od: Chen, T, i dr.
Izdano: (2004)

Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein.
od: Plebanski, M, i dr.
Izdano: (1997)

Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases
od: Luz P. Blanco, i dr.
Izdano: (2023-04-01)

Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
od: Luz P Blanco, i dr.
Izdano: (2023-04-01)

Natural altered peptide ligands in HIV infection
od: Klenerman, P, i dr.
Izdano: (1996)

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
od: Plebanski, M, i dr.
Izdano: (1999)

Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases
od: Zijun Wang, i dr.
Izdano: (2017-02-01)

A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses.
od: Bernhard Knapp, i dr.
Izdano: (2010-07-01)

Prospect of Gut Microbiota-based Intervention in Autoimmune Disease Control
od: ZHAO Lidan, i dr.
Izdano: (2022-09-01)

Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity
od: Doryssa Hermans, i dr.
Izdano: (2023-03-01)

Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
od: Jun Liu, i dr.
Izdano: (2022-05-01)

Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
od: Bättig, P, i dr.
Izdano: (2005)

Yeast Display for the Identification of Peptide-MHC Ligands of Immune Receptors
od: Huisman, Brooke D, i dr.
Izdano: (2023)

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
od: Bachmann, M, i dr.
Izdano: (1997)

Protein and Peptide Array Analysis of Autoimmune Disease
od: William H. Robinson, i dr.
Izdano: (2002-12-01)

Quantitative analysis of the T cell receptor signaling network in response to altered peptide ligands
od: Wille, Lucia
Izdano: (2006)

Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia
od: Y. F. Hao, i dr.
Izdano: (2021-01-01)

Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system.
od: Tomoko Hayashi, i dr.
Izdano: (2012-01-01)

Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.
od: Bachmann, M, i dr.
Izdano: (1998)

Is an effective immune intervention for Alzheimer's disease in prospect?
od: Esiri, M
Izdano: (2001)

Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes.
od: Smyth, L, i dr.
Izdano: (1998)

Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases
od: Jörg Christoph Prinz
Izdano: (2023-01-01)

The Role and Potential Application of Antimicrobial Peptides in Autoimmune Diseases
od: Chunye Zhang, i dr.
Izdano: (2020-05-01)

Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
od: Sewell, A, i dr.
Izdano: (1997)

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
od: Klenerman, P, i dr.
Izdano: (1995)

West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.
od: Jung, K, i dr.
Izdano: (2012)

Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination.
od: Adil Doganay Duru, i dr.
Izdano: (2020-05-01)

Human antimicrobial peptides in autoimmunity
od: Ekaterina S. Umnyakova, i dr.
Izdano: (2020-04-01)

Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
od: Fiona Bright, i dr.
Izdano: (2021-09-01)

On the role of the innate immunity in autoimmune disease.
od: Bachmann, M, i dr.
Izdano: (2001)

Immune regulation and immunotherapy in autoimmune disease /
od: Zhang, Jingwu, 1956-, i dr.
Izdano: (2007)

Immune-Neuroendocrine Interactions and Autoimmune Diseases
od: Luis J. Jara, i dr.
Izdano: (2006-01-01)

Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets
od: Louise Magnusson, i dr.
Izdano: (2020-02-01)

The role of cytokines in the pathogenesis of autoimmune diabetes, immune intervention issues
od: Ye. B. Kravets, i dr.
Izdano: (2010-02-01)

Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses
od: Luiz Vicente Rizzo, i dr.
Izdano: (1988-11-01)

Altered Metabolic Phenotype of Immune Cells in a Spontaneous Autoimmune Uveitis Model
od: Claudia Barfüßer, i dr.
Izdano: (2021-07-01)

AUTOIMMUNE RHEUMATIC DISEASES: RESULTS AND PROSPECTS FOR RESEARCHES
od: E. L. Nasonov, i dr.
Izdano: (2015-09-01)

Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
od: Luis H. Gutiérrez-González, i dr.
Izdano: (2021-10-01)